| Trial ID: | L2305 |
| Source ID: | NCT06329674
|
| Associated Drug: |
Aju-A51
|
| Title: |
Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type2 Diabetes
|
| Interventions: |
DRUG: AJU-A51|DRUG: A51R2|DRUG: A51R3|DRUG: AJU-A51 Placebo|DRUG: A51R2 Placebo
|
| Outcome Measures: |
Primary: Changes in HbA1c, Changes in HbA1c at the 24th week after the administration of investigational products from the baseline, 24th week |
|
| Sponsor/Collaborators: |
Sponsor: AJU Pharm Co., Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
235
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2021-04-27
|
| Completion Date: |
2023-06-13
|
| Results First Posted: |
|
| Last Update Posted: |
2024-03-26
|
| Locations: |
Asan Medical Center, Seoul, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT06329674
|
